comparemela.com
Home
Live Updates
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript : compareme
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript : compareme
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript
LLY earnings call for the period ending December 31, 2023.
Related Keywords
Germany ,
China ,
Taiwan ,
Japan ,
Australia ,
Boone County ,
Indiana ,
United States ,
Research Triangle Park ,
North Carolina ,
Canada ,
Puerto Rico ,
Poland ,
Chinese ,
David Risinger Leerink ,
Eli Lilly ,
Seamus Fernandez ,
Dave Ricks ,
America Merrill Lynch ,
Terence Flynn Morgan Stanley ,
Rajesh Kumar ,
Trung Huynh ,
Chris Schott Jpmorgan ,
David Risinger ,
Johna Norton ,
Louise Chen ,
Chris Shibutani Goldman Sachs ,
Jake Van Naarden ,
Versanis Bio ,
James Shin ,
Andrew Baum Citi ,
Louise Chen Cantor Fitzgerald ,
Andrew Baum ,
Joe Fletcher ,
Carter Gould Barclays ,
Patrik Jonsson ,
Seamus Fernandez Guggenheim ,
Lauren Zierki ,
Ilya Yuffa ,
Dan Skovronsky ,
Akash Tewari ,
Mablink Biosciences ,
Steve Scala ,
Chris Schott ,
Kerry Holford ,
Geoff Meacham ,
Evan Seigerman ,
Tim Anderson ,
Terence Flynn ,
Chris Shibutani ,
Carter Gould ,
Mike Springnether ,
Mohit Bansal ,
Akash Tewari Jefferies ,
Kerry Holford Berenberg ,
Anne White ,
Morgan Stanley ,
Company Analyst ,
Approval Program ,
Barclays ,
Amgen ,
Wolfe Research ,
Tim Anderson Wolfe Research Analyst ,
James Shin Deutsche Bank Analyst ,
Wells Fargo ,
Deutsche Bank ,
Geoff Meacham Bank ,
Exchange Commission ,
Cigna ,
Carolina Or Research Triangle Park ,
Goldman Sachs ,
Elilly International ,
Vice President ,
Anat Ashkenazi ,
Lilly United ,
Michaela Irons ,
Motley Fool Stock Advisor ,
Stock Advisor ,
Chief Executive ,
Emergence Therapeutics ,
For Japan ,
Accelerated Approval Program ,
Scientific Officer ,
Project Optimus ,
Lilly Diabetes ,
Umer Raffat ,
Fargo Securities ,
Medicare Part ,
Capital Markets ,
Whati Ve ,
Maybei Ll ,
Wells Fargo Securities ,
Cantor Fitzgerald ,
Berenberg Capital Markets ,
Leerink Partners ,
,